This undated photo provided by Amarin in November 2018 shows capsules and packaging for the purified, prescription fish oil Vascepa. On Thursday, Nov. 14, 2019, government health advisers recommended broader use of the prescription-strength fish oil drug to prevent heart attack, stroke and other life-threatening health problems. (Amarin via AP)
BY MATHEW PERRONE
WASHINGTON (AP) — Government health experts on Thursday recommended broader use of a prescription-strength fish oil drug to help many more patients at risk for heart attack, stroke and related health problems.
Currently the drug, Vascepa, is approved for a relatively narrow group of patients with extremely high levels of triglycerides, a type of fat in the blood linked to heart disease.
Irish drugmaker Amarin is seeking approval for a much larger group of patients who have lower fat levels but are still at risk of heart problems, despite taking cholesterol-lowering statin drugs like Lipitor and Zocor.
The panel of advisers to the F…
BY MATHEW PERRONE
WASHINGTON (AP) — Government health experts on Thursday recommended broader use of a prescription-strength fish oil drug to help many more patients at risk for heart attack, stroke and related health problems.
Currently the drug, Vascepa, is approved for a relatively narrow group of patients with extremely high levels of triglycerides, a type of fat in the blood linked to heart disease.
Irish drugmaker Amarin is seeking approval for a much larger group of patients who have lower fat levels but are still at risk of heart problems, despite taking cholesterol-lowering statin drugs like Lipitor and Zocor.
The panel of advisers to the F…
- Get link
- Other Apps